This course will provide current status and considered best practice in the discipline of sample management. It will focus on the traditional aspects of compound management (including how to maintain and measure quality of compounds). Recognizing the importance of biologics in drug discovery the course will also cover biological reagents and best practice in Biobanking and clinical sample management.
Those interested in the following tracks:
Dr Sue Crimmin is VP of Discovery Supply at GSK. This worldwide organization is accountable for the acquisition, development and management of GSK biological & small molecule collections and the maintenance & distribution of preclinical and clinical samples including compliance and QA. She is a recognized industry expert in sample management and automation and has worked in areas of Automation, Sample Management, HTS and IT She has held several global roles and has recently led efforts to redesign sample logistics across GSK platforms. Sue holds a PhD in Microbial Biochemistry and is a trained Lean Sigma facilitator.
Kathi Shea is the Head of Global Operations for BioStorage Technologies, a Brooks Life Science Solutions Company. She is a former President of the International Society for Biological and Environmental Repositories (ISBER) and an active member of several ISBER committees and working groups. Kathi served on the Advisory Working Group that developed the College of American Pathologists Biorepository Accreditation Program and is an active member of the CAP BAP Committee. She has over 20 years of experience leading biorepository programs and advising on the design of biorepositories, quality systems, and optimal methods for collection, preservation and annotation of biospecimen collections.